<DOC>
	<DOCNO>NCT01014065</DOCNO>
	<brief_summary>While sunitinib helpful treat kidney cancer , medication also cause side effect , include heart damage . Studies perform past look heart function detail , investigator know happen heart people start sunitinib treatment . The aim study prospectively study acute effect sunitinib heart function , overall fitness blood marker heart disease .</brief_summary>
	<brief_title>A Prospective Study Acute Cardiovascular Effects First-line Sunitinib Metastatic Renal Cell Carcinoma Patients ( SUnitinib Prospective CardiovasculaR Effect )</brief_title>
	<detailed_description>Participants undergo cardiac MRI , maximal exercise testing ( VO2 peak ) , blood urine sample 2 treatment sunitinib . An extra blood sample collect 2nd week first treatment check blood level sunitinib . We also examine routine CT scan study body composition .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Cardiotoxicity</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Histologic diagnosis metastatic renal cell carcinoma Eligible receive firstline sunitinib Willingness attend Cross Cancer Institute University Alberta studyrelated assessment Karnofsky Performance Status ( KPS ) 82 ≥ 70 Age ≥ 18 year age Adequate creatinine clearance receive gadolinium All patient bone metastasis eligible ; lesion identify weightbearing bone undergo plain film evaluate fracture risk prior CPET ; Fluent English language No contraindication MRI concern eg. , metallic implant , claustrophobia Prior systemic therapy mRCC Documented history major cardiac event last year i.e . MI , unstable angina , CABG , symptomatic CHF , CVA TIA , pulmonary embolism Pregnancy Other severe condition abnormality , judgement investigator treat oncologist , would make participation study inappropriate Unstable brain metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>sunitinib</keyword>
	<keyword>cardiac MRI</keyword>
	<keyword>maximal exercise testing</keyword>
	<keyword>biomarkers</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>